BMJ Group pandemic flu podcasts
Summary: BMJ Group brings doctors and healthcare professionals the latest updates on swine flu, including information on prevention, symptoms, testing, and treatment. We’ve published articles, podcasts, learning modules, and other resources, including information for patients, on a range of pandemic flu issues.
- Visit Website
- RSS
- Artist: webmaster@bmj.com
- Copyright: BMJ Group Publishing Ltd
Podcasts:
Dr Peter Brukner has been looking at nutrition for health, both of athletes and in the wider population. In this podcast he speaks to Professor Tim Noakes, author of The Lore of Running, originator of the central governor theory, and a strong exponent of
Gut’s education editor Mairi McLean talks to Emeran Meyer, Oppenheimer Center for Neurobiology of Stress, Division of Digestive Diseases, UCLA, about what we currently understand about probiotics, and where research is going. See also: An update on the u
Welcome to the latest in a series of podcast from EBN, where we take a closer look at commentaries from the journal. These discussions are designed to help you think about issues raised in the article, as well as the clinical applicability of the original
In this podcast, Mark Beattie discusses the editor’s highlights from the July edition of ADC. For all the papers discussed, see this month’s edition of the journal http://adc.bmj.com/content/98/7.toc.
Ralph Gregory, secretary for the Association of British Neurologists and consultant neurologist in Dorset, gets an update on multiple sclerosis research and implications for practice from Neil Robertson, professor of neurology, Cardiff University. They d
Ralph Gregory, secretary for the Association of British Neurologists and consultant neurologist in Dorset, gets an update on peripheral nerve disease research and practice from James Overell, consultant neurologist, Institute of Neurological Sciences, Gla
Where are we with stem cell treatments for stroke and Parkinson’s disease? At the Association of British Neurologists’ recent annual meeting in Glasgow, Neil Scolding, director of the Bristol Institute of Clinical Neurosciences, spoke to Keith Muir, Insti
Nearly annually, US healthcare providers face a significant downward revision to their Medicare fee schedule secondary to the application of the sustainable growth rate formula. Recent developments raise the possibility that this unsustainable situation m
We are talking tendons again in this podcast because the next International Scientific Tendinopathy Symposium has been scheduled for September 5 and 6 in Oxford, UK. This exciting event follows on from two successful conferences in Vancouver in 2012 and U
In this podcast, Mark Beattie discusses the editor’s highlights from the June edition of ADC. For all the papers discussed, see this month’s edition of the journal http://adc.bmj.com/content/98/6.toc.
Archimedes editor Dr Bob Phillips discusses March’s Archimedes questions, including what are the options for treating latent TB infection in children [http://bit.ly/145Ew3u], and can a conservative approach to the treatment of hypertrophic pyloric stenosi
Carl Askling, Ph.D., P.T., är forskare och lektor på Gymnastik och Idrottshögskolan, Stockholm och är knuten till Karolinska Institutet, Stockholm. Carl Askling har skrivit en avhandling om akuta skador av hamstringsmuskulaturen, “Hamstring Muscle Strain”
In this podcast, Mark Beattie discusses the editor’s highlights from the May edition of ADC. For all the papers discussed, see this month’s edition of the journal adc.bmj.com/content/98/5.toc
How does the profession of hospital pharmacy vary across Europe, and where are we with applying standards? Ana Herranz, member of EJHP's editorial board, asks Stephen Tomlin, consultant pharmacist, Evelina Children's Hospital, UK, and Catherine Duggan, di
What makes a good abstract? Gunar Stemer, EAHP Scientific Committee member, Torsten Hoppe-Tichy, chief pharmacist at University Hospital of Heidelberg, and Lene Juel Kjeldsen, senior researcher in clinical pharmacy, Danish Research Unit for Hospital Pharm